The biotech firm cuts its Long Wharf workforce by 15 people, or 28 percent, as it restructures to focus on a drug candidate ...

New drug discovery is extremely inefficient. Estimates of the average R&D cost per new drug are less than $1 billion to more ...

On FDA drug approvals and the American diet.

A business journalist who famously ditched her husband and job for disgraced “Pharma Bro” Martin Shkreli defended New York ...

Collaboration between giant pharmaceutical corporations and patients with very little power just doesn’t work, according to ...

The climate crisis is already impacting nearly every therapeutic area, according to a new report. Pharma marketers are ...

Getting more effective drugs for patients in need as quickly as possible should be the ultimate reward and objective.

NEWTOWN, PA — Traws Pharma, Inc. (Nasdaq: TRAW) recently announced a pivotal shift in its board with the appointment of Luba ...

Fierce Pharma’s Andrea Park and Ben Adams talk about major trends from the event that came up in conversations, including the ...

EQS-News: BRAIN Biotech AG / Key word (s): Contract BRAIN Biotech AG concludes major pharma compound transaction valued up to EUR 128.88 million from its BioIncubator 20.09.2024 / 19:50 CET/CEST ...